ORION BIOTECH OPPORTUNTES CO's ticker is ORIAW and the CUSIP is G6780C117. A total of 34 filers reported holding ORION BIOTECH OPPORTUNTES CO in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ANGELO GORDON & CO., L.P. | 60,000 | $584,000 | 0.06% |
| Empery Asset Management, LP | 39,700 | $6,000 | 0.03% |
| Radcliffe Capital Management, L.P. | 80,001 | $779,000 | 0.02% |
| Anson Funds Management LP | 15,000 | $146,000 | 0.01% |
| Segantii Capital Management Ltd | 30,000 | $292,000 | 0.01% |
| Arena Capital Advisors, LLC- CA | 111,314 | $17,000 | 0.00% |
| 683 Capital Management, LLC | 239,800 | $36,000 | 0.00% |
| Atalaya Capital Management LP | 100,000 | $15,000 | 0.00% |
| MMCAP International Inc. SPC | 159,802 | $24,000 | 0.00% |
| MARSHALL WACE, LLP | 54,995 | $536,000 | 0.00% |